CATHETER SITE SCAR

CATHETER SITE SCAR was reported 60 times

These drug classes are most commonly taken by patients reporting CATHETER SITE SCAR:

# Drug Count
0 Prostacycline Vasodilator [EPC] 15
1 Endothelin Receptor Antagonist [EPC] 10
2 gamma-Aminobutyric Acid-ergic Agonist [EPC] 9
3 Phosphodiesterase 5 Inhibitor [EPC] 8
4 Complement Inhibitor [EPC] 6
5 Osmotic Laxative [EPC] 5
6 Antisense Oligonucleotide [EPC] 4
7 Hydrolytic Lysosomal Glycosaminoglycan-specific Enzyme [EPC] 4
8 Nonsteroidal Anti-inflammatory Drug [EPC] 4
9 Soluble Guanylate Cyclase Stimulator [EPC] 4
10 Amide Local Anesthetic [EPC] 3
11 Antiarrhythmic [EPC] 3
12 Aldosterone Antagonist [EPC] 2
13 Catecholamine [EPC] 2
14 Expectorant [EPC] 2
15 Insulin Analog [EPC] 2
16 Loop Diuretic [EPC] 2
17 Provitamin D2 Compound [EPC] 2
18 Tetracycline-class Drug [EPC] 2
19 alpha-Adrenergic Agonist [EPC] 2
20 beta-Adrenergic Agonist [EPC] 2
21 Anti-epileptic Agent [EPC] 1
22 Aromatic Amino Acid Decarboxylation Inhibitor [EPC] 1
23 Aromatic Amino Acid [EPC] 1
24 Benzodiazepine [EPC] 1
25 Central alpha-2 Adrenergic Agonist [EPC] 1
26 Corticosteroid [EPC] 1
27 Cystic Fibrosis Transmembrane Conductance Regulator Potentiator [EPC] 1
28 Dihydrofolate Reductase Inhibitor Antibacterial [EPC] 1
29 Endoglycosidase [EPC] 1
30 Estrogen [EPC] 1
31 Factor Xa Inhibitor [EPC] 1
32 Glycopeptide Antibacterial [EPC] 1
33 HMG-CoA Reductase Inhibitor [EPC] 1
34 Human Immunoglobulin G [EPC] 1
35 Hydrolytic Lysosomal Glycogen-specific Enzyme [EPC] 1
36 Neonatal Fc Receptor Blocker [EPC] 1
37 Nucleoside Metabolic Inhibitor [EPC] 1
38 PCSK9 Inhibitor [EPC] 1
39 Phenothiazine [EPC] 1
40 Prostaglandin Analog [EPC] 1
41 Serotonin Reuptake Inhibitor [EPC] 1
42 Serotonin-3 Receptor Antagonist [EPC] 1
43 Sulfonamide Antimicrobial [EPC] 1
44 Sulfonylurea [EPC] 1
45 Vitamin D3 Analog [EPC] 1